What is INO's market cap?

Inovio Pharmaceuticals, Inc. (INO) is a listed stock with a live quote. The latest market cap on this page is $113M.

Where is Inovio Pharmaceuticals, Inc. headquartered?

Inovio Pharmaceuticals, Inc. is headquartered in Plymouth Meeting, PA.

How do I get INO news from the API?

Call GET /v1/news?tickers=INO. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.

How far back does INO news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for INO, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.

Is the INO price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Can I use the Pro plan commercially?

No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email sales@marketnewsapi.com.

INO · NASDAQ

Inovio Pharmaceuticals, Inc.

$1.64 -0.01 (-0.61%)

Company overview

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.

Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
Market cap: $113M
Employees: 134
Headquarters: Plymouth Meeting, PA
Website: inovio.com
CEO: Jacqueline E. Shea
Listed: December 8, 1998
P/E: -0.97
Dividend yield: 0.36%

Company financials

Revenue: $0.00
Gross profit: -$2.2M
Operating income: -$83.7M
EBITDA: -$84.2M
Net income: -$84.9M
EPS: -$1.71
Total assets: $49.8M
Total debt: $8.7M
Earnings yield: -102.73%

Revenue segmentation

By product (FY 2025)

By region (FY 2025)

No geographic segmentation.

Showing FY 2025

Price chart

INO 1D NASDAQ O1.87H2.04L1.60C1.66-0.23 (-12.17%)Vol43.26M

News

Ticker	Type	Headline	Source	Published
INOInovio Pharmaceuticals, Inc.	Stock news	Inovio: Upgrading To 'Buy' On Voceryq Accelerated Approval RRP And Competitive Advantages	Seeking Alpha	Nov 4, 1:29:28 PM ET
INOInovio Pharmaceuticals, Inc.	Stock news	4 Biotech Stocks Seeing Unusual Options Volume Today	Schaeffers Research	Nov 3, 11:36:57 AM ET
INOInovio Pharmaceuticals, Inc.	Press release	INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026	PR Newswire	Nov 2, 4:15:09 PM ET
INOInovio Pharmaceuticals, Inc.	Press release	INOVIO to Report Third Quarter 2026 Financial Results on November 10, 2026 INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...	PR Newswire	Nov 2, 4:15:00 PM ET
INOInovio Pharmaceuticals, Inc.	Press release	INOVIO to Participate in Upcoming Scientific Conferences	PR Newswire	Nov 2, 4:01:04 PM ET
INOInovio Pharmaceuticals, Inc.	Press release	INOVIO to Participate in Upcoming Scientific Conferences INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...	PR Newswire	Nov 2, 4:01:00 PM ET
INOInovio Pharmaceuticals, Inc.	Stock news	Inovio Pharmaceuticals, Inc. (INO) Discusses FDA Accelerated Approval and Commercial Launch of VOCERYQ for RRP Transcript	Seeking Alpha	Nov 2, 1:58:32 PM ET
INOInovio Pharmaceuticals, Inc.	Stock news	Inovio Wins FDA Approval for VOCERYQ, Its First Commercial Product	MarketBeat	Nov 2, 10:13:41 AM ET
INOInovio Pharmaceuticals, Inc.	Stock news	BUZZ-U.S. STOCKS ON THE MOVE-Estee Lauder, EchoStar, Marriott	Reuters	Nov 2, 9:15:40 AM ET
INOInovio Pharmaceuticals, Inc.	Stock news	BUZZ-U.S. STOCKS ON THE MOVE-Estee Lauder, EchoStar, Marriott	Reuters	Nov 2, 9:15:34 AM ET
INOInovio Pharmaceuticals, Inc.	Stock news	BUZZ-Inovio surges on FDA nod for rare throat disease	Reuters	Nov 2, 5:48:07 AM ET
INOInovio Pharmaceuticals, Inc.	Stock news	Why Inovio Pharmaceuticals Shares Are Trading Higher By Over 230%; Here Are 20 Stocks Moving Premarket	Benzinga	Nov 2, 4:29:29 AM ET
INOInovio Pharmaceuticals, Inc.	Stock news	UPDATE 3-US FDA approves Inovio's treatment for rare throat disease; shares surge	Reuters	Oct 30, 6:18:32 PM ET
INOInovio Pharmaceuticals, Inc.	Press release	INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP)	PR Newswire	Oct 30, 6:01:49 PM ET
INOInovio Pharmaceuticals, Inc.	Press release	INOVIO Announces FDA Accelerated Approval of VOCERYQ™, an Immunotherapy to Reduce the Frequency of Surgery in Adults with Recurrent Respiratory Papillomatosis (RRP) INOVIO (NASDAQ: INO), a biotechnology company focused on developing and com.	PR Newswire	Oct 30, 6:01:00 PM ET
INOInovio Pharmaceuticals, Inc.	Stock news	BRIEF-FDA Approves First Plasmid Dna-Based Immunotherapy For Adults With Recurrent Respiratory Papillomatosis	Reuters	Oct 30, 6:00:17 PM ET
INOInovio Pharmaceuticals, Inc.	Stock news	BUZZ-Inovio Pharma jumps after US FDA approves rare disease therapy	Reuters	Oct 30, 5:38:10 PM ET
INOInovio Pharmaceuticals, Inc.	Stock news	US FDA approves Inovio's treatment for rare throat disease	Reuters	Oct 30, 4:40:05 PM ET
INOInovio Pharmaceuticals, Inc.	Press release	INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protec…	PR Newswire	Oct 20, 4:05:00 PM ET
INOInovio Pharmaceuticals, Inc.	Stock news	Critical Survey: Pyxis Oncology (NASDAQ:PYXS) versus Inovio Pharmaceuticals (NASDAQ:INO)	Defense World	Oct 1, 4:15:24 AM ET

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.